Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-CA-21-049

Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed)

Closed on November 12, 2021.

Posted
July 29, 2021
Close date
November 12, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$1,980,301
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. SAGE BIONETWORKS1

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 RTRB-F (M2))1
1 award under RFA-CA-21-049 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2022Multi-Consortia Coordinating Center (MC2 Center) for Cancer Biology: Building Interdisciplinary Scientific Communities, Coordinating Impactful Resource Sharing, and Advancing Cancer Research1U24CA274494-01Bletz, Julie AnnEddy, James ASAGE BIONETWORKS, WAFirst-year cost $1,980,301Study section ZCA1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-20-0.3.9. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-CA-21-049: Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed) | ConductScience ScienceDex